We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Q30 Sports Science has secured approval from the US Food and Drug Administration (FDA) for its non-invasive device called Q-Collar to help protect athletes’ brains during head impacts.
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has been granted special approval by the German Federal Institute for Drugs and Medical Devices (BfArM) to offer the
Thermo Fisher Scientific has completed the acquisition of point-of-care molecular diagnostic company Mesa Biotech for $450m. With the acquisition is now closed, Mesa Biotech will be included into
Japanese company Olympus has exercised its option to acquire Israel-based medical device company Medi-Tate to strengthen its position in the field of urological devices. The acquisition of Medi-Tate
MatMaCorp (Materials and Machines Corporation), a developer of comprehensive molecular diagnostic systems, today announced data demonstrating the effectiveness of the company’s COVID-19 2SF RNA test in detecting variants
Withings Health Solutions has introduced a new business-to-business range of cellular-connected devices to phase out serious pain points of remote patient monitoring. The Withings Body Pro cellular smart
Welldoc has entered into a collaboration and licencing agreement with Eli Lilly to incorporate its software into Lilly’s connected insulin solutions, which are currently under development. As per
Telehealth solutions can provide significant advantages for both patients and providers, including reducing the cost of care, reducing waiting times for patients, and providing improved patient experiences and
Siren, a health technology company that pioneered the development of microsensor-embedded textiles for medical applications, announced that it is augmenting its Siren Socks product offering by launching Siren
Axonics Modulation Technologies has acquired UK-based medical products provider Contura in a deal valued at around $235m. The transaction consists of $200m in cash and stock, as well